PIK3CD and B-cell chronic lymphocytic leukemia: These same tissues show depletion of Tregs as compared to CLL patients who do not develop toxicity, suggesting that PI3K inhibitor-induced loss of Tregs may unleash the pathologic activity of pre-existing Th17 cells, leading to autoimmune toxicity.